1. Home
  2. APLS vs GOLF Comparison

APLS vs GOLF Comparison

Compare APLS & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$40.86

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Logo Acushnet Holdings Corp.

GOLF

Acushnet Holdings Corp.

HOLD

Current Price

$97.89

Market Cap

4.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLS
GOLF
Founded
2009
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.9B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
APLS
GOLF
Price
$40.86
$97.89
Analyst Decision
Hold
Hold
Analyst Count
21
7
Target Price
$32.71
$83.67
AVG Volume (30 Days)
8.0M
229.8K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
1.05%
EPS Growth
112.50
N/A
EPS
0.20
3.11
Revenue
$1,003,782,000.00
$1,633,721,000.00
Revenue This Year
N/A
$5.76
Revenue Next Year
$18.19
$2.44
P/E Ratio
$204.20
$31.14
Revenue Growth
28.46
4.71
52 Week Low
$16.10
$58.37
52 Week High
$40.87
$104.81

Technical Indicators

Market Signals
Indicator
APLS
GOLF
Relative Strength Index (RSI) 87.65 57.81
Support Level $18.53 $97.73
Resistance Level N/A $104.16
Average True Range (ATR) 0.27 2.32
MACD 1.31 0.71
Stochastic Oscillator 99.94 83.80

Price Performance

Historical Comparison
APLS
GOLF

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).

About GOLF Acushnet Holdings Corp.

Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.

Share on Social Networks: